Literature DB >> 21871003

Dose prescription and treatment planning based on FMISO-PET hypoxia.

Iuliana Toma-Dasu1, Johan Uhrdin, Laura Antonovic, Alexandru Dasu, Sandra Nuyts, Piet Dirix, Karin Haustermans, Anders Brahme.   

Abstract

PURPOSE: The study presents the implementation of a novel method for incorporating hypoxia information from PET-CT imaging into treatment planning and estimates the efficiency of various optimization approaches. Its focuses on the feasibility of optimizing treatment plans based on the non-linear conversion of PET hypoxia images into radiosensitivity maps from the uptake properties of the tracers used.
MATERIAL AND METHODS: PET hypoxia images of seven head-and-neck cancer patients were used to determine optimal dose distributions needed to counteract the radiation resistance associated with tumor hypoxia assuming various scenarios regarding the evolution of the hypoxic compartment during the treatment. A research planning system for advanced studies has been used to optimize IMRT plans based on hypoxia information from patient PET images. These resulting plans were compared in terms of target coverage for the same fulfilled constraints regarding the organs at risk.
RESULTS: The results of a planning study indicated the clinical feasibility of the proposed method for treatment planning based on PET hypoxia. Antihypoxic strategies would lead to small improvements in all the patients, but higher effects are expected for the fraction of patients with hypoxic tumors. For these, individualization of the treatment based on hypoxia PET imaging could lead to improved treatment outcome while creating the premises for limiting the irradiation of the surrounding normal tissues.
CONCLUSIONS: The proposed approach offers the possibility of improved treatment results as it takes into consideration the heterogeneity and the dynamics of the hypoxic regions. It also provides early identification of the clinical cases that might benefit from dose escalation as well as the cases that could benefit from other counter-hypoxic measures.

Entities:  

Mesh:

Year:  2011        PMID: 21871003     DOI: 10.3109/0284186X.2011.599815

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  23 in total

1.  Imaging Hypoxia with ¹⁸F-Fluoromisonidazole: Challenges in Moving to a More Complicated Analysis.

Authors:  Mark Muzi; Kenneth A Krohn
Journal:  J Nucl Med       Date:  2016-02-18       Impact factor: 10.057

Review 2.  Newer positron emission tomography radiopharmaceuticals for radiotherapy planning: an overview.

Authors:  Punit Sharma; Anirban Mukherjee
Journal:  Ann Transl Med       Date:  2016-02

Review 3.  Molecular imaging of tumor hypoxia with positron emission tomography.

Authors:  Olivia J Kelada; David J Carlson
Journal:  Radiat Res       Date:  2014-03-27       Impact factor: 2.841

Review 4.  Molecular imaging of hypoxia in non-small-cell lung cancer.

Authors:  Connie Yip; Philip J Blower; Vicky Goh; David B Landau; Gary J R Cook
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-21       Impact factor: 9.236

Review 5.  F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy.

Authors:  Joseph G Rajendran; Kenneth A Krohn
Journal:  Semin Nucl Med       Date:  2015-03       Impact factor: 4.446

Review 6.  The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities.

Authors:  Joseph C Walsh; Artem Lebedev; Edward Aten; Kathleen Madsen; Liane Marciano; Hartmuth C Kolb
Journal:  Antioxid Redox Signal       Date:  2014-05-09       Impact factor: 8.401

7.  Multimodal evaluation of hypoxia in brain metastases of lung cancer and interest of hypoxia image-guided radiotherapy.

Authors:  Samuel Valable; Jade Fantin; Aurélien Corroyer-Dulmont; Laurent Chatre; Jérôme Toutain; Sylvain Teulier; Céline Bazille; Elise Letissier; Jérôme Levallet; Didier Divoux; Méziane Ibazizène; Stéphane Guillouet; Cécile Perrio; Louisa Barré; Sébastien Serres; Nicola R Sibson; Françoise Chapon; Guénaëlle Levallet; Myriam Bernaudin
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

8.  A method for comparing intra-tumoural radioactivity uptake heterogeneity in preclinical positron emission tomography studies.

Authors:  Jonas Grafström; Hanna-Stina Ahlzén; Sharon Stone-Elander
Journal:  EJNMMI Phys       Date:  2015-09-08

Review 9.  Imaging Modalities to Assess Oxygen Status in Glioblastoma.

Authors:  Aurélien Corroyer-Dulmont; Ararat Chakhoyan; Solène Collet; Lucile Durand; Eric T MacKenzie; Edwige Petit; Myriam Bernaudin; Omar Touzani; Samuel Valable
Journal:  Front Med (Lausanne)       Date:  2015-08-19

10.  Kill-painting of hypoxic tumours in charged particle therapy.

Authors:  Walter Tinganelli; Marco Durante; Ryoichi Hirayama; Michael Krämer; Andreas Maier; Wilma Kraft-Weyrather; Yoshiya Furusawa; Thomas Friedrich; Emanuele Scifoni
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.